FORM 10-K/A

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 AMENDMENT NO. 1
                                       to
          [X]  ANNUAL REPORT  PURSUANT TO SECTION  13 OR 15(d)  OF THE
               SECURITIES EXCHANGE ACT OF 1934 [FEE REQUIRED]

                            for the fiscal year ended
                               September 30, 1997

                                       or

          [  ] TRANSITION REPORT  PURSUANT TO  SECTION 13 OR  15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

                                     1-12318
                             Commission file number

                            BALLARD MEDICAL PRODUCTS
                            Exact name of registrant 
                           as specified in its charter

                                      UTAH
                  State or other jurisdiction of incorporation 
                                 or organization

                                   87-0340144
                       I.R.S. Employer Identification No.  
                    

                 12050 Lone Peak Parkway, Draper, Utah  84020  
                              Address and Zip Code 
                         of principal executive offices

                                 (801) 572-6800
                         Registrant's telephone number, 
                              including area code 

          Securities registered to 12(b) of the Act:  None

          Securities registered pursuant to Section 12(g) of the Act: 

                           Title of Class:  Common   
                           Par Value:  $0.10 per share

          [X]  Yes  Indicate by check mark whether the Registrant (1)
           
          [ ]  No   has  filed all  reports  required to  be filed  by
                    Section 12 or 15(d) of the Securities Exchange Act
                    of  1934 during  the preceding  12 months  (or for
                    such  shorter  period  that  the   registrant  was  
                    required to  file such reports), and  (2) has been
                    subject to  such filing requirements  for the past
                    90 days.    

          [ ]       Indicate by check mark if disclosure of delinquent
                    filers  pursuant  to  Item 405  of  Regulation S-K
                    (Section 229.405 of this chapter) is not contained
                    herein, and will not be  contained, to the best of
                    registrant's  knowledge,  in  definitive proxy  or
                    information  statements incorporated  by reference
                    in  Part III of this Form 10-K or any amendment to
                    this Form 10-K.  

          The  aggregate market  value  of the  voting  stock held  by
          nonaffiliates of the registrant as of 12/11/97: 

                                  $636,534,779

          The number  of shares outstanding of  the registrant's class
          of common stock, as of 12/11/97:

                                   29,030,983

                       DOCUMENTS INCORPORATED BY REFERENCE

          The  following  documents   are  incorporated  by  reference
          herein:

                1.  Annual  Report  to  Shareholders for  fiscal  year
                    ended September 30, 1997:  Incorporated into Parts
                    I and II hereof.
            
                2.  Proxy Statement for Annual Meeting of Shareholders
                    to be  held January  26, 1998:   Incorporated into
                    Part III hereof.


                            BALLARD MEDICAL PRODUCTS

                     Cross Reference Sheet Showing Location 
                      in Annual Report or Proxy Statement 
               of Information Required by Certain Form 10-K Items


                                                               LOCATION IN
           FORM 10-K ITEMS                                     REFERENCE
                                                               MATERIALS
           Part I

                Item 1.      Business                          Annual Report,
                                                               pp. 1-8  

                Item 2.      Properties                        Annual Report,
                                                               pp. 1, 2

           Part II.

                Item 5.      Market for Registrant's Common    Annual Report 
                             Equity and Related Stockholder    p. 6
                             Matters

                Item 6.      Selected Consolidated Financial   Annual Report,
                             Data                              pp. 7-8

                Item 7.      Management's Discussion and
                             Analysis of Financial Condition   Annual Report,
                             and Results of Operations         pp. 26-33

                Item 8.      Consolidated Financial
                             Statements and Supplementary      Annual Report,
                             Data                              pp. 10-25

           Part III

                Item 10.     Directors and Executive             
                             Officers of the Registrant        Proxy Statement,
                                                               pp. 3,4, 16-19

                Item 11.     Executive Compensation            Proxy Statement,
                                                               pp. 5-11

                Item 12.     Security Ownership of Certain
                             Beneficial Owners and             Proxy Statement,
                             Management                        pp. 3-4


          ITEM 2.  PROPERTIES

               Information  required  by  this  item  is  incorporated
          herein by  reference from the  Company's Annual Report.   In
          addition, the following information is provided:

               The  Company  owns  a   378,000  square-foot  plant  on
          approximately  twenty acres  of  land in  Draper, Salt  Lake
          County, Utah.   This  facility includes a  separate finished
          goods warehouse (102,000 square feet) which was completed in
          August,  1997  at  a  construction  cost   of  approximately
          $3,367,000.

               The  Company   also  owns  a  manufacturing   plant  in
          Pocatello,   Idaho   (208,000   square   feet),   of   which
          approximately  104,000  square   feet  were  added  on   and
          completed  in April,  1997  at a  cost  of approximately  $5
          million.

               On April  29, 1997,  the Company sold  approximately 61
          acres of BREH's  real estate (located south of the Company's
          Draper  plant)  for  approximately  $3,266,000  cash  and  a
          $3,974,000 note.  The note provides, among other things, for  
          interest at 8.0%, for payment of all accrued interest in one
          year and for payment in full of all accrued interest and the
          entire  principal balance in two years.  The note is secured
          by  a first trust deed against approximately 42 acres of the
          property sold and certain related water shares.

               On  August 29, 1997 the  Company sold the  6.5 acres it
          acquired in 1996 in Fremont,  California at a purchase price
          of $2,326,000.

               MIC  closed  its   Milpitas,  California  facility  and
          terminated the building lease  effective July 31, 1997, with
          terms  which included  a  $44,000  early  cancellation  fee.
          MIC's  manufacturing  operations  are  now  located  at  our
          Pocatello, Idaho plant. 

               We  estimate that,  once  the Cardiotronics  operations
          have been  relocated  to  Pocatello,  the  annualized  sales
          volume of  products manufactured at that plant  (on a single
          shift)  will be  approximately $65  million to  $70 million,
          with  approximately  10%  to   15%  of  the  facility  still
          available to house future product lines. 

               In  August,  1996,  the  Company  acquired,  indirectly
          through a Canadian  subsidiary, a small building (on 2 acres
          of  land)  in  Thorold, Canada,  at  a  total  cost of  U.S.
          $886,069.  This real estate purchase was made in conjunction
          with the acquisition  of PMP.   We are  currently seeking  a
          tenant for this facility.

          ITEM 8.   CONSOLIDATED     FINANCIAL     STATEMENTS      AND
                    SUPPLEMENTARY DATA

               The  Company's  consolidated   balance  sheets  as   of
          September  30, 1997  and 1996  and the  related consolidated
          statements  of  operations,  stockholders'  equity  and cash
          flows  for each  of  the three  years  in the  period  ended
          September 30, 1997 are incorporated herein by reference from
          the Company's Annual Report.


                                   SIGNATURES

               Pursuant to the requirements of  Section 13 or 15(d) of
          the Securities Exchange Act of 1934, the Registrant has duly
          caused  this  report  to be  signed  on  its  behalf by  the
          undersigned thereunto duly authorized.

          Date:  December 22, 1997      BALLARD MEDICAL PRODUCTS

                                        By:  Dale H. Ballard
                                             President, Director
                                             (Principal Executive  
                                             Officer)

               Pursuant to the requirements of the Securities Exchange
          Act  of 1934,  this  report has  been  signed below  by  the
          following persons  on behalf of  the Registrant  and in  the
          capacities and on the dates indicated.

          Date:  December 22, 1997      By:  Dale H. Ballard
                                             Director

          Date:  December 22, 1997      By:  E. Martin Chamberlain
                                             Director

          Date:  December 22, 1997      By:  Dale H. Ballard, Jr.
                                             Director

          Date:  December 22, 1997      By:  Paul W. Hess
                                             Director

          Date:  December 22, 1997      By:  Kenneth R. Sorenson
                                             Treasurer (Principal
                                             Financial Officer)


                            BALLARD MEDICAL PRODUCTS

                                Index to Exhibits

           EXHIBIT     EXHIBIT DESCRIPTION   SEQUENTIALLY NUMBERED PAGE
           NO.

            3.1        Restated Certificate  Incorporated herein by
                       of Incorporation,     reference to Exhibit 3.1 to
                       dated June 18, 1987   Form 10-K, filed December
                                             29, 1989.

            3.2        July 10, 1991         Incorporated herein by
                       Articles of           reference to Exhibit 4.2 to
                       Amendment to          the Registration Statement
                       Articles of           on Form S-3, filed November
                       Incorporation         13, 1991, Registration No.
                                             33-43910.

            3.3        September 20, 1993    Incorporated herein by
                       Articles of           reference to Exhibit 3.3 to
                       Amendment to          Form 10-K filed December
                       Articles of           16, 1993.
                       Incorporation  

            3.4        Amended and Restated  Incorporated herein by
                       Bylaws, dated         reference to Exhibit 3.3 to
                       October 12, 1992      Form 10-K, filed December
                                             24, 1992.

            4.1        See Exhibits 3.1,
                       3.2, 3.3, 10.1,
                       10.2, 10.3, 10.4,
                       10.5, 10.6, 10.7,
                       10.8 and 10.9

            9          None

           10.1        Material Contract:    Incorporated herein by
                       1988 Incentive Stock  reference to the
                       Option Plan           Registration Statement on
                                             Form S-8, filed November
                                             18, 1988, Registration No.
                                             33-25628.

           10.2        Material Contract:    Incorporated herein by
                       1990 Incentive Stock  reference to the
                       Option Plan           Registration Statement on
                                             Form S-8, filed September
                                             17, 1990, Registration No.
                                             33-36851.

           10.3        Material Contract:    Incorporated herein by
                       1991 Incentive Stock  reference to Exhibit 4.2 to
                       Option Plan           Registration Statement on
                                             Form S-8, filed July 10,
                                             1991, Registration No. 33-
                                             41720.

           10.4        Material Contract:    Incorporated herein by
                       1992 Incentive Stock  reference to Exhibit 4.3 to
                       Option Plan           Registration Statement on
                                             Form S-8, filed with Post-
                                             Effective Amendment No. 1
                                             on April 9, 1993,
                                             Registration No. 33-56302.  

           10.5        Material Contract:    Incorporated herein by
                       Amended and Restated  reference to Exhibit 4.5 to
                       1993 Incentive Stock  Registration Statement on
                       Option Plan           Form S-8, filed December
                                             20, 1993, Registration No.
                                             33-73194.

           10.6        Material Contract:    Incorporated herein by
                       1994 Incentive Stock  reference to Exhibit 10.8
                       Option Plan           to Form 10-K filed December
                                             15, 1994. 

           10.7        Material Contract:    Incorporated herein by
                       1995 Incentive Stock  reference to Exhibit 10.9
                       Option Plan           to Form 10-K filed December 
                                             8, 1995. 

           10.8        Material Contract:    Incorporated herein by
                       1996 Incentive Stock  reference to Exhibit 10.10
                       Option Plan           to Form 10-K filed December
                                             9, 1996

           10.9        Material Contract:    p.
                       1997 Incentive Stock
                       Option Plan

           10.10       Material Contract:    Incorporated herein by
                       Agreement of          reference to Exhibit 19 to
                       Settlement dated      Form 10-Q, filed May 15,
                       March 1, 1990, with   1990.
                       Smiths Industries
                       Medical Systems,
                       Inc. and Smiths
                       Industries PLC

           10.11       Material Contract:    Incorporated herein by
                       Agreement dated       reference to Exhibit 10.21
                       effective October 1,  to Form 10-K, filed
                       1993 between Ballard  December 16, 1993.
                       Medical Products and
                       H. Earl Wright and
                       The Wright Foamer
                       Co.

           10.12       Material Contract:    Incorporated herein by
                       Stock Purchase        reference to Exhibit 99.1
                       Agreement (with       to Form 8-K, filed December
                       various "Sellers"     23, 1996.
                       named therein)  

           10.13       Material Contract:    Incorporated herein by
                       Stock Purchase        reference to Exhibit 99.2
                       Agreement (with SO-   to Form 8-K, filed December
                       CAL PARTNERS, L.P.,   23, 1996.
                       as "Seller")

           10.14       Material Contract:    Incorporated herein by
                       Merger Agreement      reference to Exhibit 99.3
                                             to Form 8-K, filed December
                                             23, 1996.

           11          Computation of        p.
                       Income Per Common
                       Share and Common
                       Equivalent Share

           12          Not Applicable

           13          Ballard Medical       p.
                       Products 1997 Annual
                       Report for the year
                       ended September 30,
                       1997

           16          Not Applicable

           18          Not Applicable

           21          Subsidiaries of       p.
                       Ballard Medical
                       Products

           22          Not Applicable

           23          Independent
                       Auditor's Consent     p.

           24          Not Applicable

           25          Not Applicable

           26          Not Applicable

           27          Financial Data        p.
                       Schedule

           28          Not Applicable